The DxRx Summit will be attended by investors, corporate management, business leaders, legal & regulatory advisors, clinical trial CROs and others who are interested in the diagnostic and therapeutic applications of DNA, RNAi, microRNAs, and antisense technology.

Registered delegates will also be eligible to attend a half-day interactive business tutorial on the market and business landscape for diagnostics and therapeutics based on RNAi and microRNAs hosted by Enal Razvi, PhD.

Agenda Topics may include:

Reviews of Company Pipelines
Clinical Trial Status of Nucleic Acid-Based Therapeutics
Patent Status of Nucleic Acid-Based Diagnostics and Therapeutics
Nucleic Acid Drug Delivery
microRNAs as Diagnostics and Therapeutic Entities
Nucleic Acid Biomarkers for Personalized Medicine
Reimbursement and Regulatory Landscape
Investor Attitudes to this Sector
Emerging Company Showcase